| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | 2.23e-03 | 265 | 20 | 3 | GO:0042393 | |
| Domain | - | 7.45e-03 | 122 | 20 | 2 | 3.40.30.10 | |
| Domain | Thioredoxin-like_fold | 8.67e-03 | 132 | 20 | 2 | IPR012336 | |
| Pubmed | 1.43e-06 | 1014 | 21 | 7 | 32416067 | ||
| Pubmed | 3.13e-05 | 102 | 21 | 3 | 26584622 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.25e-05 | 1082 | 21 | 6 | 38697112 | |
| Pubmed | Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs. | 1.40e-04 | 29 | 21 | 2 | 11997339 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.90e-04 | 1489 | 21 | 6 | 28611215 | |
| Pubmed | 4.35e-04 | 51 | 21 | 2 | 34316707 | ||
| Pubmed | 4.52e-04 | 52 | 21 | 2 | 22219177 | ||
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 5.06e-04 | 55 | 21 | 2 | 23178491 | |
| Cytoband | 17p11.2 | 2.40e-03 | 159 | 21 | 2 | 17p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p11 | 3.87e-03 | 203 | 21 | 2 | chr17p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 1.53e-02 | 415 | 21 | 2 | chr12q24 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.82e-06 | 192 | 21 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.10e-06 | 199 | 21 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.14e-06 | 200 | 21 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.81e-05 | 162 | 21 | 3 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.81e-05 | 162 | 21 | 3 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | C_00|World / shred on cell type and cluster | 7.81e-05 | 179 | 21 | 3 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-05 | 188 | 21 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.18e-05 | 189 | 21 | 3 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.62e-05 | 192 | 21 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.76e-05 | 193 | 21 | 3 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 198 | 21 | 3 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.05e-04 | 198 | 21 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.07e-04 | 199 | 21 | 3 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-04 | 199 | 21 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.07e-04 | 199 | 21 | 3 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-04 | 200 | 21 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.08e-04 | 200 | 21 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Computational | Neighborhood of RBBP6 | 9.15e-05 | 70 | 14 | 3 | GNF2_RBBP6 | |
| Disease | infant head circumference | 4.10e-05 | 15 | 19 | 2 | EFO_0004577 | |
| Disease | hip circumference | 1.26e-03 | 338 | 19 | 3 | EFO_0005093 | |
| Disease | prostate carcinoma | 2.23e-03 | 891 | 19 | 4 | EFO_0001663 | |
| Disease | serum gamma-glutamyl transferase measurement | 2.44e-03 | 914 | 19 | 4 | EFO_0004532 | |
| Disease | Polydactyly | 2.55e-03 | 117 | 19 | 2 | C0152427 | |
| Disease | Malignant neoplasm of breast | 4.37e-03 | 1074 | 19 | 4 | C0006142 | |
| Disease | blood phosphate measurement | 5.53e-03 | 174 | 19 | 2 | EFO_0010972 | |
| Disease | prostate specific antigen measurement | 6.43e-03 | 188 | 19 | 2 | EFO_0004624 | |
| Disease | Hypermetropia, Myopia | 6.50e-03 | 189 | 19 | 2 | HP_0000540, HP_0000545 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MEQSCEEEKEPEPQK | 1 | Q86YH2 | |
| EPEMAKDCDREDIPI | 201 | Q8IYA2 | |
| SDSDKPCKEEPMEVD | 1131 | Q12830 | |
| KREEPMEEEEEPEQK | 596 | P49756 | |
| MEEEEEPEQKPCLKP | 601 | P49756 | |
| ECDLMESIEPDVVKP | 181 | P57729 | |
| VDCEPMVIDKLPFDK | 316 | Q5JSJ4 | |
| EPEMEFEIEPDKECK | 426 | Q9H307 | |
| REMPKAEEKEVPEDS | 731 | Q3BBV0 | |
| EPEMAKDCDREDIPI | 251 | Q3MJ40 | |
| KKDMSPPFICEETDE | 706 | Q8NDI1 | |
| EKKAAAPAPEEEMDE | 251 | P26641 | |
| QMSKDKEAVDECEPP | 91 | P57679 | |
| EPEMAKDCDREDIPI | 251 | A2RUR9 | |
| TMKVPVVKEDDEPEE | 216 | A3KN83 | |
| EEPRDEEEEAKMKAP | 221 | P05423 | |
| KTMEPEEEVEDDPKV | 91 | O15119 | |
| CMEATPEVKEDPKEV | 241 | Q99457 | |
| DEKIEVDDPPDKEDM | 141 | Q9HCE3 | |
| KPEEETMEFPEGDKV | 436 | Q86VQ3 | |
| DLEEECEPEEMLKTP | 801 | O43379 | |
| FEEEETKEMPKLQCE | 971 | Q8NAP3 | |
| TKDDKEDPELMKCPV | 881 | Q01538 |